Details

NameSymbolSector
BERYL DRUGS LTD.BERLDRGPharmaceuticals
Open
23.02
High
23.5
Low
22
Close
23.5
Volume
418
Exchange
bse
Time
15-Jun-2026

Outlook

Score:  

3

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Beryl Drugs is  
None
Estimated Stoploss of Beryl Drugs is ₹  
22
Beryl Drugs has a  
Bullishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Beryl Drugs is  
Unpredictableℹ
. 

Trend

Beryl Drugs is in  
Sideways trendℹ
. 
Price of Beryl Drugs is  
Upℹ
 by  

8

%. 
Target
Buy @ 

17.77

Sell @ 

25.43

Current @ 

23.5

Volume

The trade volumes of Beryl Drugs have become  
Deficientℹ
Though the volume trend for Beryl Drugs appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Beryl Drugs is  

Down

 by  

90.84

% 

Valuation

The current market price of Beryl Drugs is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 15cr and total assets worth ₹ 15cr, the balance sheet of Beryl Drugs is:  
Balancedℹ
. 
Cashflow
Beryl Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

66.67% i.e. ₹ 2cr earned in operatingℹ
0% in investingℹ
33.33% i.e. ₹ 1cr spent in financingℹ
0% in otherℹ
Beryl Drugs has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

0% in operatingℹ
100% i.e. ₹ 1cr spent in investingℹ
0% in financingℹ
0% in otherℹ
Income
The income of Beryl Drugs is  

₹ 5cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Beryl Drugs Losses increased by:  

0

% and Income is Up by:  

25

% 

(*Sep 2025)

The income of Beryl Drugs is  

₹ 4cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Beryl Drugs Losses increased by:  

0

% and Income is Down by:  

20

% 

(*Jun 2025)

The income of Beryl Drugs is  

₹ 5cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Beryl Drugs Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.